The LOXL3 gene helps your body strengthen collagen, a key material in connective tissue that supports the eyes, joints, palate, and other structures. This gene plays an important role in building and stabilizing these tissues as you grow. When both copies of the gene do not work properly, it can cause a connective tissue condition that may include very strong nearsightedness, hearing changes, joint looseness, and differences in the roof of the mouth or facial features. The LOXL3 gene is mainly known in medical genetics rather than public culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes carry the instructions for producing proteins, which are the functional parts of cells. Others mainly help determine when, where, and how much certain activities take place. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, see the LearnHub.
Overview
LOXL3Gene function
What if the gene works
The LOXL3 gene helps build and strengthen connective tissue by helping collagen and elastin form stable links. This supports tissues such as the eyes, skin, joints, and developing bones.
Risk
What if the gene does not work
More disruptive variants in the LOXL3 gene can cause a connective tissue condition, often with severe nearsightedness, eye changes, and sometimes cleft palate, hearing loss, or spine and joint problems. Milder variants may lead to a narrower set of features.
Treatment
What does that mean for your treatment
No LOXL3-specific treatment or management approach is currently established. Care is guided by the person’s symptoms rather than by a drug chosen for the LOXL3 gene itself. The LOXL3 gene is being studied in cancer and tissue scarring research as a possible biomarker or drug target, but this has not led to guideline-based treatment.
Gene function
What if the gene works
Your body depends on connective tissue to hold its shape and stay resilient in daily movement. The LOXL3 gene helps cells strengthen this supportive material by helping collagen and elastin fibers settle into a stable network. This helps explain the LOXL3 gene’s function in connective tissue, where both firmness and flexibility matter.
LOXL3 protein works outside cells, where it helps collagen fibers form firm links with each other. These links give tissues steady structure and support.
It also helps elastin fibers make stable links. This supports tissues that need to stretch and return to shape, such as parts of the skin, lungs, and blood vessels.
By strengthening collagen and elastin, the LOXL3 gene helps maintain the extracellular matrix (the supportive material around cells). This framework helps tissues keep their form during everyday wear and repair.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the LOXL3 gene can alter how the protein folds, binds copper, or is released outside the cell, which may leave it less stable or less active. More disruptive variants can reduce or stop enzyme activity, while milder variants may leave some function intact. This range helps explain how variants in the LOXL3 gene affect protein function and, in some people, why related eye or connective tissue features may appear earlier or be more pronounced.
How variants are linked to conditions
Pathogenic variants in the LOXL3 gene can cause a rare recessive form of Stickler syndrome. In affected families, this may include severe nearsightedness, retinal problems, cleft palate, hearing changes, and joint findings. Some studies also link the LOXL3 gene to early onset high myopia, especially when two altered copies are inherited. These findings show how LOXL3 gene variants linked to Stickler syndrome can shape genetic diagnosis and follow-up care.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widespread in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LOXL3 gene. For many living with a LOXL3 gene change, risk is mainly linked to the specific change inherited, and a doctor or genetic counselor can help explain what that means for you or your family.
Inheritance of LOXL3 variants
LOXL3-related conditions are inherited in an autosomal recessive pattern. For families asking how LOXL3 gene variants are inherited, this usually means a person needs to inherit one changed copy of the LOXL3 gene from each parent to have the condition. Parents who each carry one variant are often unaffected themselves, and with each pregnancy there is a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without the familial variant. Boys and girls are affected equally.
What does my LOXL3 result mean for my family?
For LOXL3, family impact is mainly discussed for a recessive inherited condition, including a form of Stickler syndrome. This usually means parents can be healthy carriers, and brothers or sisters may also be affected or may be carriers. Other relatives may want to know about the result too, especially if there is a family history of similar eye, hearing, joint, or cleft palate features.
Genetic information
Genetic testing
How you find out about variants
Variants in the LOXL3 gene are found with LOXL3 genetic testing, usually using a blood sample or saliva sample. A lab reads the gene’s DNA code and checks for changes linked to a person’s symptoms or family history. Results may show a pathogenic variant, a benign variant, or an uncertain result.
When should I consider getting a genetic test?
Testing for LOXL3 may be considered if someone has signs of a rare inherited condition affecting connective tissue, such as severe nearsightedness from childhood, retinal detachment, hearing loss, cleft palate, or joint problems, especially when these run in the family. A result can help confirm whether LOXL3 is the cause.
A genetic result is only one part of your health story
A genetic finding can be very informative, but what it can tell you varies with the condition and the kind of variant present. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. In some conditions, particularly those shaped by many genes, genetic information provides context instead of certainty and makes the most sense when viewed together with other parts of care. In other situations, a genetic result can give a clear answer. For topics like medication response, genetic results may help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment works well for one person but less well for another. These differences are common and can influence both how well a medicine works and the chance of side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It studies gene and drug patterns to help explain why the same treatment works differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the LOXL3 gene
When should I seek medical advice?
This gene does not currently have a broadly confirmed role in how medicines are chosen or used, so questions about side effects, medication response, or your overall health are best discussed with your doctor or pharmacist.
History
The LOXL3 gene entered genetics research later than some better known inherited condition genes, first as part of the lysyl oxidase family identified in studies of connective tissues. In the early 2000s, researchers began describing LOXL3 more clearly and separating it from related family members. From these first observations, research expanded steadily. By the 2010s, reports linked variants in the LOXL3 gene to inherited conditions affecting the eyes, face, and connective tissues, which gave the gene clearer clinical relevance. More recent work has helped refine which LOXL3 variants are disease causing and how they fit into broader genetic testing for these conditions.